Epitopix entered into a global licensing agreement with Pfizer Animal Health (now Zoetis) for Epitopix’s E. coli O157 vaccine; licensing of the Epitopix Salmonella Newport vaccine followed in 2011.
Epitopix entered into a global licensing agreement with Pfizer Animal Health (now Zoetis) for Epitopix’s E. coli O157 vaccine; licensing of the Epitopix Salmonella Newport vaccine followed in 2011.